Long-Term Follow-Up of a Pilot Phase II Study with Neoadjuvant Epidoxorubicin, Etoposide and Cisplatin in Gastric Cancer

Publisher： Karger

E-ISSN： 1423-0232|67|1|48-53

ISSN： 0030-2414

Source： Oncology, Vol.67, Iss.1, 2004-10, pp. : 48-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced or Metastatic Bladder Cancer: Long-Term Follow-Up of a 3-Week Regimen

By  

Oncology, Vol. 69, Iss. 5, 2005-12 ,pp. : 391-398

Karger

Access to resources Recommend Favorite

Paclitaxel in the Neoadjuvant Treatment for Adeno carcinoma of the Distal Esophagus (AEG I). A Comparison of Two Phase II Trials with Long-Term Follow-Up

By  

Oncology Research and Treatment, Vol. 31, Iss. 7, 2008-06 ,pp. : 366-372

Karger

Access to resources Recommend Favorite

A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up

By  

Acta Haematologica, Vol. 137, Iss. 1, 2016-11 ,pp. : 7-14

Karger

Access to resources Recommend Favorite

Hyperbaric Oxygen Therapy for Radiation Cystitis in Patients with Prostate Cancer: A Long-Term Follow-Up Study

By  

Urologia Internationalis, Vol. 89, Iss. 2, 2012-07 ,pp. : 208-214

Karger

Access to resources Recommend Favorite

Postmastectomy internal mammary node radiation in women with breast cancer: a long-term follow-up study

By  

Journal of Radiotherapy in Practice, Vol. 14, Iss. 4, 2015-06 ,pp. : 385-393

Cambridge University Press

Access to resources Recommend Favorite